Overview of cefixime use in community-acquired infections

Clin Microbiol Infect. 2000:6 Suppl 3:79-81. doi: 10.1111/j.1469-0691.2000.tb02051.x.

Author

J M Hamilton-Miller¹

Affiliation

¹ Department of Medical Microbiology, Royal Free and University College Medical School, London, UK. j.hamilton-miller@rfhsm.ac.uk

PMID: 11449661
DOI: 10.1111/j.1469-0691.2000.tb02051.x

No abstract available

Publication types

Review

MeSH terms

Cefixime / pharmacology
Cefixime / therapeutic use*
Cefixime / urine
Cephalosporins / pharmacology
Cephalosporins / therapeutic use*
Cephalosporins / urine
Community-Acquired Infections / drug therapy*
Community-Acquired Infections / microbiology
Escherichia coli Infections / drug therapy
Female
Haemophilus Infections / drug therapy
Humans
Male
Neisseriaceae Infections / drug therapy
Patient Compliance
Respiratory Tract Infections / drug therapy
Respiratory Tract Infections / microbiology
Staphylococcal Infections / drug therapy
Streptococcal Infections / drug therapy
Urinary Tract Infections / drug therapy
Urinary Tract Infections / microbiology

Substances

Cephalosporins
Cefixime